Watchlist Price Alert

Chemomab Therapeutics Ltd... (CMMB)

NASDAQ: CMMB · Real-Time Price · USD

1.22

0.00 (0.00%)

At close: May 07, 2025, 2:40 PM

Chemomab Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	6.07M	9.29M	13.52M	14.69M	11.67M	17.58M	7.52M	1.45M	4.56M
Short-Term Investments	8.2M	10.49M	26.37M	46.48M	24K	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	55K	4K	130K	120K	n/a	n/a
Other Long-Term Assets	378.38K	559K	733K	908K	53K	57K	1.34M	279K	567.73K
Receivables	263K	289K	n/a	179K	74K	636K	3.4M	88K	139.01K
Inventory	1.00	n/a	n/a	-47.5M	-657K	-542	-77K	n/a	1.00
Other Current Assets	76K	76K	536K	n/a	n/a	515K	23K	n/a	1.00
Total Current Assets	16.04M	20.9M	41.74M	62.69M	11.84M	18.21M	10.92M	1.59M	4.87M
Property-Plant & Equipment	539K	695K	594K	702K	580K	1.36M	385K	219K	213.32K
Goodwill & Intangibles	6.62K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	924K	1.25M	1.33M	1.67M	637K	1.54M	1.84M	498K	781.05K
Total Assets	16.96M	22.15M	43.06M	64.35M	12.48M	19.76M	12.76M	2.09M	5.65M
Account Payables	666K	516K	1.69M	1.34M	93K	25K	396K	160K	106.53K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	2.00	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	391K	n/a	n/a	n/a
Other Current Liabilities	874K	823K	n/a	n/a	n/a	3.05M	1.62M	2.54M	2.25M
Total Current Liabilities	3.22M	4.84M	6.75M	2.65M	1.32M	4.12M	2.75M	2.7M	2.36M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	617K	210K	n/a	n/a
Total Long-Term Liabilities	209K	316K	91K	237K	358K	725K	210K	n/a	n/a
Total Liabilities	3.43M	5.15M	6.84M	2.89M	1.67M	4.85M	2.96M	2.7M	2.36M
Total Debt	324K	392K	214K	343K	428K	1.12M	n/a	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.77M	1.92M
Retained Earnings	-102.62M	-88.68M	-63.82M	-36.17M	-23.7M	-105.43M	-78.31M	-62.88M	-52.7M
Comprehensive Income	0.00	n/a	-0.00	0.00	872K	872K	4.44M	2.22M	1.32M
Shareholders Equity	13.54M	17M	36.22M	61.47M	10.8M	14.91M	9.8M	-609K	3.29M
Total Investments	8.2M	10.49M	26.37M	46.48M	28K	130K	120K	n/a	n/a